Exact Mass: 313.1477992

Exact Mass Matches: 313.1477992

Found 81 metabolites which its exact mass value is equals to given mass value 313.1477992, within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error 0.001 dalton.

3,4-dimethylidenehexanedioylcarnitine

3-[(5-carboxy-3,4-dimethylidenepentanoyl)oxy]-4-(trimethylazaniumyl)butanoate

C15H23NO6 (313.1525298)


3,4-dimethylidenehexanedioylcarnitine is an acylcarnitine. More specifically, it is an 3,4-dimethylidenehexanedioic acid ester of carnitine. Acylcarnitines were first discovered more than 70 year ago (PMID: 13825279). It is believed that there are more than 1000 types of acylcarnitines in the human body. The general role of acylcarnitines is to transport acyl-groups (organic acids and fatty acids) from the cytoplasm into the mitochondria so that they can be broken down to produce energy. This process is known as beta-oxidation. According to a recent review [Dambrova et al. 2021, Physiological Reviews], acylcarnitines (ACs) can be classified into 9 different categories depending on the type and size of their acyl-group: 1) short-chain ACs; 2) medium-chain ACs; 3) long-chain ACs; 4) very long-chain ACs; 5) hydroxy ACs; 6) branched chain ACs; 7) unsaturated ACs; 8) dicarboxylic ACs and 9) miscellaneous ACs. Short-chain ACs have acyl-groups with two to five carbons (C2-C5), medium-chain ACs have acyl-groups with six to thirteen carbons (C6-C13), long-chain ACs have acyl-groups with fourteen to twenty once carbons (C14-C21) and very long-chain ACs have acyl groups with more than 22 carbons. 3,4-dimethylidenehexanedioylcarnitine is therefore classified as a medium chain AC. As a medium-chain acylcarnitine 3,4-dimethylidenehexanedioylcarnitine is somewhat less abundant than short-chain acylcarnitines. These are formed either through esterification with L-carnitine or through the peroxisomal metabolism of longer chain acylcarnitines (PMID: 30540494). Many medium-chain acylcarnitines can serve as useful markers for inherited disorders of fatty acid metabolism. Carnitine octanoyltransferase (CrOT, EC:2.3.1.137) is responsible for the synthesis of all medium-chain (MCAC, C5-C12) and medium-length branched-chain acylcarnitines in peroxisomes (PMID: 10486279). The study of acylcarnitines is an active area of research and it is likely that many novel acylcarnitines will be discovered in the coming years. It is also likely that many novel roles in health and disease will be uncovered. An excellent review of the current state of knowledge for acylcarnitines is available at [Dambrova et al. 2021, Physiological Reviews].

   

Octa-3,5-dienedioylcarnitine

3-[(7-Carboxyhepta-3,5-dienoyl)oxy]-4-(trimethylazaniumyl)butanoic acid

C15H23NO6 (313.1525298)


Octa-3,5-dienedioylcarnitine is an acylcarnitine. More specifically, it is an octa-3,5-dienedioic acid ester of carnitine. Acylcarnitines were first discovered more than 70 year ago (PMID: 13825279). It is believed that there are more than 1000 types of acylcarnitines in the human body. The general role of acylcarnitines is to transport acyl-groups (organic acids and fatty acids) from the cytoplasm into the mitochondria so that they can be broken down to produce energy. This process is known as beta-oxidation. According to a recent review [Dambrova et al. 2021, Physiological Reviews], acylcarnitines (ACs) can be classified into 9 different categories depending on the type and size of their acyl-group: 1) short-chain ACs; 2) medium-chain ACs; 3) long-chain ACs; 4) very long-chain ACs; 5) hydroxy ACs; 6) branched chain ACs; 7) unsaturated ACs; 8) dicarboxylic ACs and 9) miscellaneous ACs. Short-chain ACs have acyl-groups with two to five carbons (C2-C5), medium-chain ACs have acyl-groups with six to thirteen carbons (C6-C13), long-chain ACs have acyl-groups with fourteen to twenty once carbons (C14-C21) and very long-chain ACs have acyl groups with more than 22 carbons. octa-3,5-dienedioylcarnitine is therefore classified as a medium chain AC. As a medium-chain acylcarnitine octa-3,5-dienedioylcarnitine is somewhat less abundant than short-chain acylcarnitines. These are formed either through esterification with L-carnitine or through the peroxisomal metabolism of longer chain acylcarnitines (PMID: 30540494). Many medium-chain acylcarnitines can serve as useful markers for inherited disorders of fatty acid metabolism. Carnitine octanoyltransferase (CrOT, EC:2.3.1.137) is responsible for the synthesis of all medium-chain (MCAC, C5-C12) and medium-length branched-chain acylcarnitines in peroxisomes (PMID: 10486279). The study of acylcarnitines is an active area of research and it is likely that many novel acylcarnitines will be discovered in the coming years. It is also likely that many novel roles in health and disease will be uncovered. An excellent review of the current state of knowledge for acylcarnitines is available at [Dambrova et al. 2021, Physiological Reviews].

   

Octa-2,6-dienedioylcarnitine

3-[(7-Carboxyhepta-2,6-dienoyl)oxy]-4-(trimethylazaniumyl)butanoic acid

C15H23NO6 (313.1525298)


Octa-2,6-dienedioylcarnitine is an acylcarnitine. More specifically, it is an octa-2,6-dienedioic acid ester of carnitine. Acylcarnitines were first discovered more than 70 year ago (PMID: 13825279). It is believed that there are more than 1000 types of acylcarnitines in the human body. The general role of acylcarnitines is to transport acyl-groups (organic acids and fatty acids) from the cytoplasm into the mitochondria so that they can be broken down to produce energy. This process is known as beta-oxidation. According to a recent review [Dambrova et al. 2021, Physiological Reviews], acylcarnitines (ACs) can be classified into 9 different categories depending on the type and size of their acyl-group: 1) short-chain ACs; 2) medium-chain ACs; 3) long-chain ACs; 4) very long-chain ACs; 5) hydroxy ACs; 6) branched chain ACs; 7) unsaturated ACs; 8) dicarboxylic ACs and 9) miscellaneous ACs. Short-chain ACs have acyl-groups with two to five carbons (C2-C5), medium-chain ACs have acyl-groups with six to thirteen carbons (C6-C13), long-chain ACs have acyl-groups with fourteen to twenty once carbons (C14-C21) and very long-chain ACs have acyl groups with more than 22 carbons. octa-2,6-dienedioylcarnitine is therefore classified as a medium chain AC. As a medium-chain acylcarnitine octa-2,6-dienedioylcarnitine is somewhat less abundant than short-chain acylcarnitines. These are formed either through esterification with L-carnitine or through the peroxisomal metabolism of longer chain acylcarnitines (PMID: 30540494). Many medium-chain acylcarnitines can serve as useful markers for inherited disorders of fatty acid metabolism. Carnitine octanoyltransferase (CrOT, EC:2.3.1.137) is responsible for the synthesis of all medium-chain (MCAC, C5-C12) and medium-length branched-chain acylcarnitines in peroxisomes (PMID: 10486279). The study of acylcarnitines is an active area of research and it is likely that many novel acylcarnitines will be discovered in the coming years. It is also likely that many novel roles in health and disease will be uncovered. An excellent review of the current state of knowledge for acylcarnitines is available at [Dambrova et al. 2021, Physiological Reviews].

   

(2Z,4Z)-Octa-2,4-dienedioylcarnitine

(2Z,4Z)-Octa-2,4-dienedioylcarnitine

C15H23NO6 (313.1525298)


(2Z,4Z)-octa-2,4-dienedioylcarnitine is an acylcarnitine. More specifically, it is an (2Z,4Z)-octa-2,4-dienedioic acid ester of carnitine. Acylcarnitines were first discovered more than 70 year ago (PMID: 13825279). It is believed that there are more than 1000 types of acylcarnitines in the human body. The general role of acylcarnitines is to transport acyl-groups (organic acids and fatty acids) from the cytoplasm into the mitochondria so that they can be broken down to produce energy. This process is known as beta-oxidation. According to a recent review [Dambrova et al. 2021, Physiological Reviews], acylcarnitines (ACs) can be classified into 9 different categories depending on the type and size of their acyl-group: 1) short-chain ACs; 2) medium-chain ACs; 3) long-chain ACs; 4) very long-chain ACs; 5) hydroxy ACs; 6) branched chain ACs; 7) unsaturated ACs; 8) dicarboxylic ACs and 9) miscellaneous ACs. Short-chain ACs have acyl-groups with two to five carbons (C2-C5), medium-chain ACs have acyl-groups with six to thirteen carbons (C6-C13), long-chain ACs have acyl-groups with fourteen to twenty once carbons (C14-C21) and very long-chain ACs have acyl groups with more than 22 carbons. (2Z,4Z)-octa-2,4-dienedioylcarnitine is therefore classified as a medium chain AC. As a medium-chain acylcarnitine (2Z,4Z)-octa-2,4-dienedioylcarnitine is somewhat less abundant than short-chain acylcarnitines. These are formed either through esterification with L-carnitine or through the peroxisomal metabolism of longer chain acylcarnitines (PMID: 30540494). Many medium-chain acylcarnitines can serve as useful markers for inherited disorders of fatty acid metabolism. Carnitine octanoyltransferase (CrOT, EC:2.3.1.137) is responsible for the synthesis of all medium-chain (MCAC, C5-C12) and medium-length branched-chain acylcarnitines in peroxisomes (PMID: 10486279). The study of acylcarnitines is an active area of research and it is likely that many novel acylcarnitines will be discovered in the coming years. It is also likely that many novel roles in health and disease will be uncovered. An excellent review of the current state of knowledge for acylcarnitines is available at [Dambrova et al. 2021, Physiological Reviews].

   

Octa-3,6-dienedioylcarnitine

3-[(7-Carboxyhepta-3,6-dienoyl)oxy]-4-(trimethylazaniumyl)butanoic acid

C15H23NO6 (313.1525298)


Octa-3,6-dienedioylcarnitine is an acylcarnitine. More specifically, it is an octa-3,6-dienedioic acid ester of carnitine. Acylcarnitines were first discovered more than 70 year ago (PMID: 13825279). It is believed that there are more than 1000 types of acylcarnitines in the human body. The general role of acylcarnitines is to transport acyl-groups (organic acids and fatty acids) from the cytoplasm into the mitochondria so that they can be broken down to produce energy. This process is known as beta-oxidation. According to a recent review [Dambrova et al. 2021, Physiological Reviews], acylcarnitines (ACs) can be classified into 9 different categories depending on the type and size of their acyl-group: 1) short-chain ACs; 2) medium-chain ACs; 3) long-chain ACs; 4) very long-chain ACs; 5) hydroxy ACs; 6) branched chain ACs; 7) unsaturated ACs; 8) dicarboxylic ACs and 9) miscellaneous ACs. Short-chain ACs have acyl-groups with two to five carbons (C2-C5), medium-chain ACs have acyl-groups with six to thirteen carbons (C6-C13), long-chain ACs have acyl-groups with fourteen to twenty once carbons (C14-C21) and very long-chain ACs have acyl groups with more than 22 carbons. octa-3,6-dienedioylcarnitine is therefore classified as a medium chain AC. As a medium-chain acylcarnitine octa-3,6-dienedioylcarnitine is somewhat less abundant than short-chain acylcarnitines. These are formed either through esterification with L-carnitine or through the peroxisomal metabolism of longer chain acylcarnitines (PMID: 30540494). Many medium-chain acylcarnitines can serve as useful markers for inherited disorders of fatty acid metabolism. Carnitine octanoyltransferase (CrOT, EC:2.3.1.137) is responsible for the synthesis of all medium-chain (MCAC, C5-C12) and medium-length branched-chain acylcarnitines in peroxisomes (PMID: 10486279). The study of acylcarnitines is an active area of research and it is likely that many novel acylcarnitines will be discovered in the coming years. It is also likely that many novel roles in health and disease will be uncovered. An excellent review of the current state of knowledge for acylcarnitines is available at [Dambrova et al. 2021, Physiological Reviews].

   

Sematilide

N-[2-(Diethylamino)ethyl]-4-methanesulphonamidobenzamide

C14H23N3O3S (313.1460048)


   
   
   
   
   
   

1-ethenamino-7-(5-oxohex-1-ynyl)phenanthrene

1-ethenamino-7-(5-oxohex-1-ynyl)phenanthrene

C22H19NO (313.14665640000004)


   
   
   
   
   
   
   
   
   
   
   
   
   
   

Sematilide

Sematilide

C14H23N3O3S (313.1460048)


C78274 - Agent Affecting Cardiovascular System > C47793 - Antiarrhythmic Agent D002317 - Cardiovascular Agents > D000889 - Anti-Arrhythmia Agents

   

3-Quinolinecarboxylic acid, 1-cyclopropyl-1,4-dihydro-4-oxo-7-(1-piperazinyl)

3-Quinolinecarboxylic acid, 1-cyclopropyl-1,4-dihydro-4-oxo-7-(1-piperazinyl)

C17H19N3O3 (313.1426344)


   

3-AMINO-N,N-DIETHYL-4-MORPHOLIN-4-YL-BENZENESULFONAMIDE

3-AMINO-N,N-DIETHYL-4-MORPHOLIN-4-YL-BENZENESULFONAMIDE

C14H23N3O3S (313.1460048)


   

ethyl 1-(6-formylquinazolin-4-yl)piperidine-3-carboxylate

ethyl 1-(6-formylquinazolin-4-yl)piperidine-3-carboxylate

C17H19N3O3 (313.1426344)


   

Ethyl 2-amino-4,5-bis(2-methoxyethoxy)benzoate

Ethyl 2-amino-4,5-bis(2-methoxyethoxy)benzoate

C15H23NO6 (313.1525298)


   

1-(4-Methoxyphenyl)-4-(4-nitrophenyl)piperazine

1-(4-Methoxyphenyl)-4-(4-nitrophenyl)piperazine

C17H19N3O3 (313.1426344)


   

ethyl 1-(6-formylquinazolin-4-yl)piperidine-4-carboxylate

ethyl 1-(6-formylquinazolin-4-yl)piperidine-4-carboxylate

C17H19N3O3 (313.1426344)


   

Benzenemethanaminium,N,N,N-tripropyl-, bromide (1:1)

Benzenemethanaminium,N,N,N-tripropyl-, bromide (1:1)

C16H28BrN (313.14049880000005)


   
   

1-Naphthyl(1-propyl-1H-indol-3-yl)methanone

1-Naphthyl(1-propyl-1H-indol-3-yl)methanone

C22H19NO (313.14665640000004)


   

N-[2-Isopropylthiazol-4-ylmethyl(methyl)carbamoyl]-L-valine

N-[2-Isopropylthiazol-4-ylmethyl(methyl)carbamoyl]-L-valine

C14H23N3O3S (313.1460048)


   

3-(Dimethylamino)-1-(6-(3-methoxyphenyl)-7,7a-dihydroimidazo[2,1-b]oxazol-5-yl)prop-2-en-1-one

3-(Dimethylamino)-1-(6-(3-methoxyphenyl)-7,7a-dihydroimidazo[2,1-b]oxazol-5-yl)prop-2-en-1-one

C17H19N3O3 (313.1426344)


   

P-TOLYLTETRAZOLIUM RED

P-TOLYLTETRAZOLIUM RED

C20H17N4+ (313.1453142)


   

Acecainide hydrochloride

N-AcetylprocainaMide hydrochloride

C15H24ClN3O2 (313.15569539999996)


C78274 - Agent Affecting Cardiovascular System > C47793 - Antiarrhythmic Agent D002317 - Cardiovascular Agents > D000889 - Anti-Arrhythmia Agents C93038 - Cation Channel Blocker

   

7,8-Dihydro-6-hydroxymethyl-7-methyl-7-[2-phenylethyl]-pterin

7,8-Dihydro-6-hydroxymethyl-7-methyl-7-[2-phenylethyl]-pterin

C16H19N5O2 (313.15386739999997)


   

L-Histidylglycyl-L-threonine

L-Histidylglycyl-L-threonine

C12H19N5O5 (313.1386124)


   

1-isopropyl-3-(3,4-dimethoxyphenyl)-1H-pyrazolo[3,4-d]pyrimidin-4-amine

1-isopropyl-3-(3,4-dimethoxyphenyl)-1H-pyrazolo[3,4-d]pyrimidin-4-amine

C16H19N5O2 (313.15386739999997)


   

(1R,2R,5R,8R,9S,10R,11S)-11-methyl-6-methylidene-16-oxo-15-oxapentacyclo[9.3.2.15,8.01,10.02,8]heptadec-13-ene-9-carboxylate

(1R,2R,5R,8R,9S,10R,11S)-11-methyl-6-methylidene-16-oxo-15-oxapentacyclo[9.3.2.15,8.01,10.02,8]heptadec-13-ene-9-carboxylate

C19H21O4- (313.14397660000003)


   

(2S)-2-[(E)-[(2S)-2-amino-3-(4-hydroxyphenyl)propylidene]amino]-3-(4-hydroxyphenyl)propanal

(2S)-2-[(E)-[(2S)-2-amino-3-(4-hydroxyphenyl)propylidene]amino]-3-(4-hydroxyphenyl)propanal

C18H21N2O3+ (313.15520960000003)


   

(2S)-2-[[(2E,6E)-7-carboxy-3-methylocta-2,6-dienyl]amino]pentanedioic acid

(2S)-2-[[(2E,6E)-7-carboxy-3-methylocta-2,6-dienyl]amino]pentanedioic acid

C15H23NO6 (313.1525298)


   

3,4-dimethylidenehexanedioylcarnitine

3,4-dimethylidenehexanedioylcarnitine

C15H23NO6 (313.1525298)


   

Octa-3,5-dienedioylcarnitine

Octa-3,5-dienedioylcarnitine

C15H23NO6 (313.1525298)


   

Octa-2,6-dienedioylcarnitine

Octa-2,6-dienedioylcarnitine

C15H23NO6 (313.1525298)


   

Octa-3,6-dienedioylcarnitine

Octa-3,6-dienedioylcarnitine

C15H23NO6 (313.1525298)


   

(2Z,4Z)-Octa-2,4-dienedioylcarnitine

(2Z,4Z)-Octa-2,4-dienedioylcarnitine

C15H23NO6 (313.1525298)


   

N-(2,4-dimethylphenyl)-4-[2-(2-furylmethylene)hydrazino]-4-oxobutanamide

N-(2,4-dimethylphenyl)-4-[2-(2-furylmethylene)hydrazino]-4-oxobutanamide

C17H19N3O3 (313.1426344)


   

N-(6-Butyrylamino-pyridin-3-yl)-2-methoxy-benzamide

N-(6-Butyrylamino-pyridin-3-yl)-2-methoxy-benzamide

C17H19N3O3 (313.1426344)


   

[2-[(2,6-dimethyl-4-morpholinyl)-oxomethyl]phenyl]-(1H-imidazol-2-yl)methanone

[2-[(2,6-dimethyl-4-morpholinyl)-oxomethyl]phenyl]-(1H-imidazol-2-yl)methanone

C17H19N3O3 (313.1426344)


   

1-(4-Fluorophenyl)-3-(4-morpholinyl)-2-phenyl-1-propanone

1-(4-Fluorophenyl)-3-(4-morpholinyl)-2-phenyl-1-propanone

C19H20FNO2 (313.1477992)


   
   
   
   
   
   
   
   
   
   
   
   

1-(3-Fluorophenyl)-3-(4-morpholinyl)-2-phenyl-1-propanone

1-(3-Fluorophenyl)-3-(4-morpholinyl)-2-phenyl-1-propanone

C19H20FNO2 (313.1477992)


   

1-(2-Fluorophenyl)-3-(4-morpholinyl)-2-phenyl-1-propanone

1-(2-Fluorophenyl)-3-(4-morpholinyl)-2-phenyl-1-propanone

C19H20FNO2 (313.1477992)


   
   

12,13-dihydroxy-13-(3-methylimidazol-4-yl)-1-azatricyclo[6.4.2.0²,⁷]tetradeca-2,4,6-trien-9-one

12,13-dihydroxy-13-(3-methylimidazol-4-yl)-1-azatricyclo[6.4.2.0²,⁷]tetradeca-2,4,6-trien-9-one

C17H19N3O3 (313.1426344)


   

(8s,12r,13s)-12,13-dihydroxy-13-(1-methylimidazol-4-yl)-1-azatricyclo[6.4.2.0²,⁷]tetradeca-2,4,6-trien-9-one

(8s,12r,13s)-12,13-dihydroxy-13-(1-methylimidazol-4-yl)-1-azatricyclo[6.4.2.0²,⁷]tetradeca-2,4,6-trien-9-one

C17H19N3O3 (313.1426344)


   

3-[(3r,9s,9ar)-9-hydroxy-2-oxo-octahydroquinolizin-3-yl]quinazolin-4-one

3-[(3r,9s,9ar)-9-hydroxy-2-oxo-octahydroquinolizin-3-yl]quinazolin-4-one

C17H19N3O3 (313.1426344)


   

6-hydroxy-4-[(2r,3r)-2-hydroxy-3-[(2s,3s)-2-hydroxy-3-methyl-4-methylideneoxolan-2-yl]-3-methoxypropyl]-4,5-dihydro-3h-pyridin-2-one

6-hydroxy-4-[(2r,3r)-2-hydroxy-3-[(2s,3s)-2-hydroxy-3-methyl-4-methylideneoxolan-2-yl]-3-methoxypropyl]-4,5-dihydro-3h-pyridin-2-one

C15H23NO6 (313.1525298)


   

(8s,12s,13s)-12,13-dihydroxy-13-(3-methylimidazol-4-yl)-1-azatricyclo[6.4.2.0²,⁷]tetradeca-2,4,6-trien-9-one

(8s,12s,13s)-12,13-dihydroxy-13-(3-methylimidazol-4-yl)-1-azatricyclo[6.4.2.0²,⁷]tetradeca-2,4,6-trien-9-one

C17H19N3O3 (313.1426344)


   

12,13-dihydroxy-13-(1-methylimidazol-4-yl)-1-azatricyclo[6.4.2.0²,⁷]tetradeca-2,4,6-trien-9-one

12,13-dihydroxy-13-(1-methylimidazol-4-yl)-1-azatricyclo[6.4.2.0²,⁷]tetradeca-2,4,6-trien-9-one

C17H19N3O3 (313.1426344)


   

3-[(4r,9s,9ar)-9-hydroxy-2-oxo-octahydroquinolizin-4-yl]quinazolin-4-one

3-[(4r,9s,9ar)-9-hydroxy-2-oxo-octahydroquinolizin-4-yl]quinazolin-4-one

C17H19N3O3 (313.1426344)


   

6-hydroxy-4-[2-hydroxy-3-(2-hydroxy-3-methyl-4-methylideneoxolan-2-yl)-3-methoxypropyl]-4,5-dihydro-3h-pyridin-2-one

6-hydroxy-4-[2-hydroxy-3-(2-hydroxy-3-methyl-4-methylideneoxolan-2-yl)-3-methoxypropyl]-4,5-dihydro-3h-pyridin-2-one

C15H23NO6 (313.1525298)


   

3-(9-hydroxy-2-oxo-octahydroquinolizin-4-yl)quinazolin-4-one

3-(9-hydroxy-2-oxo-octahydroquinolizin-4-yl)quinazolin-4-one

C17H19N3O3 (313.1426344)